Cross-Linked Diselenide Nanovesicles against Acute Liver Injury by Seamless Integration of ROS Elimination and Source Inhibition.
The persistent rise in case incidence and the acute shortage of effective treatments have heightened the urgent need for robust strategies to combat acute liver injury (ALI). Targeting reactive oxygen species (ROS) scavenging remains the predominant therapeutic approach. However, current clinical interventions and emer...